Medicine and Dentistry
Glioblastoma
100%
Positron Emission Tomography
77%
Carbon 11
75%
Magnetic Resonance Imaging
71%
Methionine
66%
Neoplasm
60%
Tumor Progression
51%
Ganglioglioma
50%
Ventricle of Heart
42%
Positron Emission Tomography
35%
Systematic Review
33%
Meta-Analysis
33%
Diagnostic Accuracy
33%
Standardized Uptake Value
28%
Overall Survival
22%
Radiation Therapy
21%
Prognostication
19%
Treatment Planning
18%
Stereotactic Radiotherapy
16%
Perfusion Weighted Imaging
16%
Brain Metastasis
16%
Brain Tumor
16%
Cancer Treatment
16%
Lactic Acid
16%
Radioactive Tracer
16%
Treatment Response
16%
Isocitrate Dehydrogenase
16%
Meningioma
16%
Imaging Technique
16%
Voxel-Based Morphometry
16%
Multimodal Imaging
16%
Proportional Hazards Model
12%
Progression Free Survival
11%
Fluorine-18
10%
Disease
8%
Gray Matter
8%
Edema
7%
Clinical Decision Making
6%
Clinical Management
6%
Hemisphere
6%
Amino Acid
6%
Progressive Disease
6%
Sensitivity and Specificity
5%
Neuro-Oncology
5%
Keyphrases
Glioblastoma
66%
Perfusion MRI
25%
Tumor Progression
17%
Advanced Magnetic Resonance Imaging
16%
Clinical Significance
16%
Diffusion Tensor Imaging
16%
Treatment Evaluation
16%
11C-methionine PET
16%
Subventricular Zone
16%
Treatment Decisions
16%
Volume-based
16%
PET Parameters
16%
In Vivo MR Spectroscopy
16%
Concomitant Chemotherapy
16%
High-grade Glioma
16%
Prognostic Value
16%
Isocitrate Dehydrogenase 1 (IDH1)
16%
Combined Modality Therapy
16%
White Matter Volume
16%
Adjuvant Chemotherapy
16%
Voxel-based Morphometry
16%
Standardized Uptake Value
16%
Glioma Patients
16%
Volume Loss
16%
11C-methionine
16%
Pseudoprogression
15%
Overall Survival
13%
MET-PET
13%
White Matter
13%
Methionine Metabolism
13%
C-11
13%
Radiotherapy Dose
13%
Diagnostic Uncertainty
12%
Fluid-attenuated Inversion Recovery (FLAIR)
11%
Conventional MRI
10%
11C-MET
10%
18F-fluoroethyl-L-tyrosine (18F-FET)
10%
Radiotherapy
10%
Tumor-free
10%
Metabolic Tumor Volume
10%
Advanced MRI
8%
Treatment Monitoring
8%
Clinical Decision-making
8%
Pseudoresponse
6%
Neovascularization
6%
Tumor Invasiveness
6%
Significant Loss
6%
Value-based
6%
Gray Matter
6%
Volume Parameters
6%
Neuroscience
Magnetic Resonance Imaging
72%
Positron Emission Tomography
54%
Methionine
50%
Magnetic Resonance Imaging
50%
Radiation Therapy
35%
Subventricular Zone
23%
Positron Emission Tomography
20%
Voxel-Based Morphometry
16%
Brain Tumor
16%
Imaging Technique
16%
Meta-Analysis
16%
Diffusion Tensor Imaging
16%
Meningioma
16%
Diffusion Imaging
16%
In Vivo Magnetic Resonance Spectroscopy
16%
Isocitrate Dehydrogenase
16%
Clinical Decision Making
13%
Gray Matter
8%
In Vivo
6%
Low-Grade Glioma
6%
